Allergan names new financial leader
February 5, 2018Allergan said Monday it has named Matt Walsh, an experienced Chief Financial Officer, to lead the financial sector of the company.
In the press release, Allergan has announced Walsh as a leader with a strong track record of creating value for shareholders, including 14 years as a CFO with three public companies and ten years in health care as CFO at Catalentwhere he led their transformation under private equity, a successful IPO and numerous acquisition and divestiture transactions, all while driving sustained organic growth.
Brent L. Saunders, Chairman and Chief Executive Officer at Allergan, said: “Matt brings to Allergan a unique combination of skills, including a technical background, a deep understanding of the healthcare industry, a rich experience across financial disciplines, and the ability to lead complex health care organizations.”
“I’m very excited to join Allergan’s fast-paced, results oriented culture. I look forward to working with Brent and the leadership team to realize Allergan’s long-term growth potential in the U.S. and internationally, as well as unlocking additional value through the Open Science R&D pipeline,” said Matt Walsh.
